Multiple factors 3, 4 have been proposed as participating in iT reg generation and much emphasis has been placed on the cytokine microenvironment, in particular the involvement of transforming growth factor-β1 (TGF-β1). Nevertheless, the upstream signals that give rise to iT regs thus far remain poorly characterized.
Previous studies 5 showed that an important early event during T effector cell activation is that the cognate interaction of CD4 + T cells with dendritic cells (DCs) amplifies T cell and DC synthesis of the alternative pathway (AP) complement components C3, factor B (fB), factor D (fD) in conjunction with C5 and the G-protein coupled receptors (GPCRs) C3a and C5a receptors (C3aR and C5aR). Concurrent with this, both T cells and DCs downregulate their expression of the cell surface C3 and C5 convertase inhibitor, decay accelerating factor (DAF or CD55). In the absence of the inhibitory effect of DAF, C3 and C5 convertases stably assemble from the locally produced C3, fB, and fD at the adjoining DC-CD4 + T cell surfaces. These enzymes act on the nascent C3 and C5 to generate C3a and C5a. The C3a and C5a anaphylatoxins, like cytokines, engage C3aR and C5aR on both the DCs and CD4 + T cells and transduce GPCR signals into both partners. When C3aR and C5aR signaling were simultaneously disabled, a marked reduction in both costimulatory and survival signals was needed for effector T cell responses [5] [6] [7] . Moreover, C3aR and C5aR signaling was also required for the differentiation of T H 1 cells and T H 17 cells, as signaling via these receptors mediated the production of interleukin-12 (IL-12) by DCs and expression of the IL-12 receptor (IL-12R) by CD4 + T cells 8 , as well as the production of IL-6 and IL-23 8 . Some data has suggested that C5aR signaling in DCs is essential for biasing T cell differentiation into a T H 17 response 8, 9 , but the role of GPCR signaling within the CD4 + T cells themselves was not investigated. In contrast, other studies indicated that signaling via C3aR and C5aR is important in both responding T cells and DCs 5, 7 .
The major consequences of C3aR and C5aR signaling are the production of IL-6 11 , IL-12 and the promotion of T H 17 differentiation 5, 7 . iT reg induction is suppressed in such a cytokine milieu 3, 4, [10] [11] [12] . Therefore, we hypothesized that the absence of C3aR and C5aR signal transduction in both responder CD4 + T cells and DCs might promote the production of iT regs . Here, we demonstrate that the concurrent absence of C3aR and C5aR GPCR signal transduction into CD4 + T cells results in the induction of a high percentage of iT regs in an endogenous TGF-β1-dependent fashion. The iT regs that are generated when CD4 + T cells are devoid of both GPCR signals manifest potent suppressor function and stability both in vitro and in vivo. Human iT regs with potent suppressor activity can be induced exploiting this new insight, a finding that potentially could have therapeutic importance. CD4 + T cells resulted in induction of ~6% Foxp3 + T cells. Furthermore, a much higher percentage of Foxp3 + T cells (~27%) was observed when Foxp3 − T cells from C3ar1 −/− C5ar1 −/− mice were similarly stimulated (Fig. 1a) . Incubation for longer times (5 days) did not significantly change the differences between the single and double knockouts (not shown). No Foxp3 + cells were induced in the absence of added IL-2 (not shown). To test whether the induced Foxp3 + cells exerted suppressor activity characteristic of iT regs , we incubated sorted Foxp3 + cells generated from each genotype in decreasing (T eff /T reg ) ratios with sorted wild type (WT) Foxp3 − CD4 + T cells prelabeled with CellTracker Red and activated with anti-CD3+CD28. Foxp3 + cells derived from the single knockouts exerted suppressor activity similar to that of sorted Foxp3 + cells induced from WT Foxp3 − CD4 + T cells with exogenously added TGF-β1 (Fig. 1b) . However, sorted Foxp3 + cells derived from the C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells exerted greater suppressor activity (Fig. 1b) . Induced C3ar1 −/− C5ar1 −/− Foxp3 + CD4 + T cells resembled tT regs in that they failed to produce IL-2 following phorbol ester (PMA) and ionomycin treatment 3 and were anergic to anti-CD3+CD28 stimulation 3 (not shown). To verify that the effects of the C3aR and C5aR knockouts apply in WT CD4 + T cells, we stimulated sorted WT Foxp3 − CD4 + T cells in the presence of C3aR and C5aR pharmaceutical antagonists (C3aR-A/C5aR-A) or in the presence of anti-C3a and C5a monoclonal antibodies (mAbs) specific for neo-epitopes in the C3a and C5a ligands, in each case individually or together. Few Foxp3 + T cells (6.5-8%) were generated when WT CD4 + T cells were cultured with an individual pharmaceutical receptor antagonist or mAb against C3a or C5a, whereas a much higher percentage (~28%) was induced when both receptors or both ligands were blocked (Fig. 1c) . Thus, the simultaneous lack of transmission of C3aR and C5aR GPCR signals into naive CD4 + T cells in the absence of DCs leads to the efficient induction of Foxp3 + cells possessing robust suppressor activity (Fig. 1b) . Although these results are consistent with previous findings ( Supplementary Fig. 1 ) 5 that autocrine C3aR and C5aR signaling operates tonically in CD4 + cells 5 , these previous data also showed that DCs produce much more C3a and C5a per cell. As the above data show, however, the absence or presence of transmitted C3aR and C5aR GPCR signals in the T cells themselves influences T cell differentiation.
Supernatants from stimulated C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells contained lower levels of IL-6 but higher levels of IL-10 and TGF-β1 than supernatants from stimulated WT Foxp3 − WT CD4 + T cells (Fig. 1d) . This finding suggested that the absence of C3aR plus C5aR signaling in CD4 + T cells resulted in the endogenous production of TGF-β1 needed for the induction of Foxp3 + cells. This appeared to be the case, as the induction of Foxp3 + T cells from C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells was inhibited when we added anti-TGF-β1 mAb, or specific antagonists of TGF-βR1 or of TGF-βR1 downstream signaling (Smad3 inhibitor) to the induction cultures (Fig. 1e) . Thus, analogous to auto-inductive cytokine signaling loops that are mechanistically connected with the induction of T H 1, Th2, and T H 17 cells 13 , TGF-β1 generated from stimulated CD4 + T cells, that are devoid of C3aR and C5aR GPCR signals, amplifies its own production and this auto-inductive signaling loop is essential for iT reg induction (Fig. 1e) . Consequently, absent C3aR plus C5aR signaling into naïve CD4 + cells enables auto-inductive TGF-β1 signaling and defines a previously unidentified autocrine signaling loop that is connected with Foxp3 + iT reg lineage commitment ( Supplementary Fig. 2 ).
Absent T cell C3aR and C5aR signals controls DCs
As T cells are activated by DCs physiologically, we next stimulated sorted WT or C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells with anti-CD3 and IL-2 in the presence of WT DCs with or without added TGF-β1. Foxp3 + cells were induced in both cases in the presence of added TGF-β1 (Fig. 2a) . Only low numbers of Foxp3 + T cells (~6%) were induced in cultures of C3ar1 −/− or C5ar1 −/− Foxp3 − CD4 + T cells containing WT DCs without added TGF-β1 ( Supplementary Fig. 3a) . However, almost as many Foxp3 + cells were induced from C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells (45-65%) in the absence of TGF-β1 (Fig. 2a) as in the presence of TGF-β1. Thus, even in the presence of C3aR and C5aR signaling by DCs, the absence of C3aR and C5aR signaling in the responder CD4 + T cells dominates and iT regs are induced.
Prior findings that DCs produce up to 1000-fold more copies of C3a and C5a per cell than cognate CD4 + T cells during effector cell activation 5 suggested that absent C3a plus C5a production by the DC and the consequent lack of C3aR plus C5aR signaling into the CD4 + T cell would influence iT reg induction during CD4 + T cell-DC interactions. To test this, we first stimulated WT Foxp3 − CD4 + T cells with C3 −/− C5 −/− DCs (note, C5 is also known as Hc) i.e. antigen presenting cells unable to produce C3 and C5 in the absence of added TGF-β1 (Fig. 2b left) . Foxp3 + cells were induced, but the addition of C3a and C5a markedly reduced the induction. Identical results were observed with WT Foxp3 − CD4 + T cells and WT DCs in the presence of TGF-β1 (Fig. 2b right) . The suppressor activity of the Foxp3 + cells that were induced in the presence of C3a and C5a in both cases also was markedly attenuated (Supplementary Fig. 3b) Fig. 3d ) but had no effect in mixtures containing C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells (Fig. 2d) . Taken together, these data support the proposition that absent C3a and C5a production by the DC and absent C3aR and C5aR signaling into CD4 + T cells are involved in iT reg induction.
Although absent C3aR and C5aR signaling into CD4 + T cells was necessary and sufficient to evoke iT reg induction in the absence of DCs (Fig. 1a) , 10-fold more TGF-β1 was produced (Fig. 2e) (Fig. 2e) . The enhanced TGF-β1 production in WT-WT mixtures, however, was accompanied by markedly enhanced production of IL-6 (Fig. 2e) potentially resulting in inhibition of T reg induction and favoring T H 17 cell polarization. The substitution of C3ar1 −/− C5ar1 −/− DCs for WT DCs in the mixtures with C3ar1 −/− C5ar1 −/− CD4 + T cells further increased TGF-β1 production and reciprocally decreased IL-6 production compared to the mixtures containing WT DCs and C3ar1 −/− C5ar1 −/− CD4 + T cells (Fig. 2e) .
To understand why greater numbers of iT regs with more potent suppressor activity are generated in the absence of C3aR and C5aR signaling compared to iT regs generated from WT CD4 + T cells with exogenously added TGF-β1, we analyzed DCs in the induction cultures following iT reg generation under the two conditions. Phenotyping of DCs from the cultures of WT DCs and stimulated C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells showed that the lack of C3aR and C5aR signaling only in the CD4 + T cells led to markedly reduced amounts of CD80 (MFI 8±1 vs 79±5), CD86 (MFI 8±1 vs 40±2) and CD40 (MFI 19±1 vs 58±3) on the surface of DC ( Supplementary Fig. 4a ) compared to those on DCs from cultures in which Foxp3 + cells were induced from WT Foxp3 − CD4 + T cells with added TGF-β1, indicating that that iT regs generated from C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + more potently prevented DC maturation. Other studies have demonstrated that TGF-β1 generated by T regs can exert a feedback effect to downregulate DC costimulatory molecule expression and thereby maintain DC immaturity 14 . Moreover, iT regs generated from C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells expressed 4.5-fold lower levels of IL-6 receptor (IL-6R) and contained 12-fold less STAT3 phosphorylation than iT regs generated from WT Foxp3 − T cells with added TGF-β1 ( Supplementary Fig. 4b ). The inclusion of anti-C3a plus anti-C5a mAbs or C3aR-A plus C5aR-A in the induction cultures generated from WT Foxp3 − T cells with added TGF-β1 reduced p-STAT3 and IL-6R levels on the iT regs to those on iT regs generated from C3ar1 −/− C5ar1 −/− T cells ( Supplementary Fig. 4b and 4c) . Analogously, TGF-β1 that is endogenously produced by iT regs devoid of C3aR and C5aR signals feedback on DCs partners and retain an immature phenotype.
T cell signaling without C3aR and C5aR parallels tT regs
During activation of conventional T cells, protein kinase A (PKA) activation is repressed and AKT phosphorylation (at T 308 S 473 ) is increased 15 . The decrease in PKA activation opposes the phosphorylation and nuclear translocation of the transcription factor CREB and the increase in T 308 S 473 AKT enhances the phosphoinositide-3 kinase (PI-3K)-p-AKTmammalian target of Rapamycin (mTOR) signaling cascade as well as enabling phosphorylation of p-AKT targets 15 . During conventional T cell activation, C3aR and C5aR signaling is mechanistically connected with CD28 and CD40L costimulation 5, 7 . The C3aR and C5aR GPCRs are Gi coupled GPCRs such that when they are bound by their ligands, the Gαi subunits of their activated G proteins suppress activation of adenylyl cyclase needed for PKA activation ( Supplementary Fig. 5 ). The Gβγ subunits activate PI-3Kγ 16, 17 needed for phosphorylating AKT at T 308 and S 473 5 . Downstream T 308 S 473 -AKT signaling maintains mTOR complex-1 in an activated state that inhibits TGF-β1 production 18, 19 and sustains phosphorylation of ribosomal S6 (rbS6) needed for the proliferation of conventional T cells ( Supplementary Fig. 5 ).
As the intracellular signaling in activated tT regs differs from that in activated conventional T cells in that PKA is activated 20, 21 and AKT dephosphorylated 20 , we examined whether iT regs induced in the absence of C3aR and C5aR signaling resembles the signaling properties of tT regs . We first tested how individually or dually disrupting C3aR and C5aR signal transduction into CD4 + T cells affects the PKA and AKT activation pathways. Consistent with C3aR and C5aR signals synergizing in CD4 + T cells to lower PKA levels during T effector cell responses, adding C3a or C5a individually to anti-CD3 stimulated WT CD4 + T cells reduced adenylyl cyclase activity by 40% and 50%, and adding both in combination reduced adenylyl cyclase activity by >95% (Fig. 3b ) thereby repressing PKA activation. In contrast, the lack of transmission of C3aR or C5aR signals individually into CD4 + T cells enhanced PKA activation by 40% and 50% and the concurrent absence of both GPCR signals enhanced PKA activation by 90% (Fig. 3c ). C3aR and C5aR signals in CD4 + T cells synergize to activate PI-3Kγ 5 . Sorted Foxp3 + cells generated from anti-CD3+CD28 stimulated C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells expressed markedly reduced S 473 p-AKT and T 308 p-AKT levels (Fig. 3d) . The repressed levels of S 473 p-AKT and T 308 p-AKT inhibit p-AKT dependent regulation of p-AKT targets and mTORC-1 dependent activation rbS6 (Fig. 3e) . Anti-CD3+CD28 stimulated C3ar1 −/− C5ar1 −/− CD4 + T cells expressed pSmad2 (Fig. 3f) , a transcription factor needed for TGF-β1 production and for Foxp3 gene transcription [22] [23] [24] [25] . Moreover, in contrast to activated conventional WT T cells generated from anti-CD3+CD28 treated WT Foxp3 − CD4 + T cells which contained p-STAT3 downstream of IL-6 signaling but not p-STAT5 downstream of CD25 signaling, anti-CD3+CD28 treated C3ar1 −/− C5ar1 −/− CD4 + T cells contained p-STAT5 but not p-STAT3 (Fig. 3g) . Thus, the signaling cascades that operate in iT regs induced from stimulated CD4 + devoid of C3aR and C5aR signals parallel those in activated tT regs .
TGF-β regulates local complement and C5L2 expression
To understand how absent C3aR and C5aR signaling in CD4 + T cells is mechanistically connected with iT reg induction, we first examined the effect of added TGF-β1 on local complement production by DCs and CD4 + T cells. Adding TGF-β1 to C5a-treated DCs ( Supplementary Fig. 6a ) or to anti-CD3+CD28 treated CD4 + T cells (Fig. 4a) abolished transcription of all of the mRNA transcripts connected with C3aR and C5aR signaling. Conversely, adding IL-6 to naive CD4 + T cells upregulated expression of C3 mRNA (Fig.  4b) , augmented C3a and C5a production (Fig. 4c) , and upregulated CD4 + T cell C3aR and C5aR expression (Fig. 4d ). IL-6 had a similar upregulatory effect on complement mRNA expression by immature DCs (Supplementary Fig. 6b ). The addition of C5a to anti-CD3+CD28-stimulated CD4 + T cells upregulated IL-6 production ( Fig. 4e) and downregulated TGF-β1 production, while blockade of C3aR and C5aR signaling down-regulated IL-6 and up-regulated TGF-β1 production ( Fig. 6c ).
Another factor relevant to the connection of TGF-β1 with suppressed C3aR and C5aR signaling is C5L2 (encoded by Gpr77), an alternative C5aR receptor of incompletely characterized function. While C5L2 has been proposed to scavenge C5a and possibly (Fig. 4f) . iT regs and DCs derived from mixtures of Foxp3 − WT CD4 + T cells and WT DCs incubated with TGF-β1 showed a similar but less pronounced increase in C5L2 and decrease in C5aR (Supplementary Fig 7a) . The up-regulation of C5L2 was enhanced in the presence of TGF-β1, as anti-CD3+CD28 activation of Foxp3 − CD4 + T cells in the presence, but not absence, of added TGF-β1 induced 7-fold up-regulation of C5L2 mRNA transcription at 48 hr ( Supplementary Fig. 7b ). To study the role C5L2 in iT reg induction, we examined iT regs induced from WT Foxp3 − CD4 + T cells (conditions in which C5L2, C3aR, and C5aR are all intact) in the presence of WT DCs and added TGF-β1. Substitution of naive C5L2 −/− CD4 + T cells for WT CD4 + T cells or substitution of C5L2 −/− DCs for WT DCs markedly reduced iT reg induction (Fig 4g) .
To clarify the mechanism by which C5L2 prevents C5aR signaling and thereby diverts CD4 + T cells away from T effector cell induction to iT reg induction, we generated iT regs from WT Foxp3 − CD4 + T cells with WT DCs and TGF-β1. We sorted the Foxp3 + and Foxp3 − populations and, following resting, we activated the purified Foxp3 + and Foxp3 − cells with anti-CD3+CD28 coated beads. We then added biotin-labeled C5a to the activated cells, isolated plasma membranes, and prepared anti-C5aR and anti-C5L2 immunoprecipitates (IPs) of the purified membrane fractions. We added equal amounts (OD 280 ) of the IP purified proteins to gels, and following electrophoresis, we probed immunoblots with streptavidin peroxidase. In the case of sorted Foxp3 + iT regs , the biotin-labeled C5a associated mainly with C5L2. Conversely, in the case of sorted Foxp3 − CD4 + T cells activated with anti-CD3+CD28 coated beads, it associated mainly with C5aR (Fig. 4h) . In control experiments, no streptavidin signal was observed and no Ig heavy and light chains were detected in anti-C5aR IPs from iT regs generated from C3ar1 −/− C5ar1 −/− Foxp3 − CD4 + T cells confirming specificity ( Supplementary Fig. 7c ). As recently demonstrated by multi-color confocal microscopy 26 , flow cytometry following permeablization showed that most of C5L2 was intracellular consistent wits presence in plasma membrane associated liposomes ( Supplementary Fig. 7d ). Thus, TGF-β1 prevents C3aR and C5aR signaling in DCs and CD4 + T cells both by inhibiting local complement production and by upregulating C5L2 expression that then sequesters C5a and possibly C3a.
iT regs without C3aR and C5aR signals are stable in vivo
One difficulty with the interpretation of the significance of in vitro generated iT regs is that they have been found to be unstable in vivo 30 . To test the stability of iT regs generated in the absence of C3a or C5a signaling, we prepared iT regs in vitro from CD4 + T cells derived from WT (CD45.2) or C3ar1 −/− C5ar1 −/− (CD45.2) Foxp3-GFP mice bred to OT-II mice expressing a transgenic (Tg) TCR for ovalbumin [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] . Foxp3 + antigen-specific iT regs were then sorted, transferred into CD45.1 recipients, and the recipients immunized with ovalbumin. While five days later only 26% of the Foxp3 + cells generated from WT OT-II cells with TGF-β1 remained Foxp3 + in the draining lymph nodes (dLN) (Fig. 5a) , 69% of the Foxp3 + iT regs derived from C3ar1 −/− C5ar1 −/− OT-II cells remained Foxp3 + . No loss of Foxp3 occurred when the mice were immunized irrelevant MOG peptide, consistent with the loss being connected with a specific TCR signal.
Although demethylation of the T reg -specific demethylation region (TSDR) of the Foxp3 locus has been associated with the stability of Foxp3 expression in tT regs compared to iT regs , methylation analyses of the TSDR region of iT regs generated ex vivo in the absence C3aR and C5aR signaling (not shown) showed that it was mostly methylated (88%) similarly to that of iT regs induced with exogenous TGF-β1. This finding suggests that factors other than the methylation status of the TSDR may control stability of Foxp3 expression in vivo as recently reported by other groups 31, 32 . Insufficient numbers of in vivo generated C3ar1 −/− C5ar1 −/− Foxp3 + OT-II iT regs could be recovered for analysis of the TSDR.
Disabled C3aR and C5aR signaling induces iT regs in vivo
We next evaluated whether absent C3aR and C5aR signaling in CD4 + T cells in vivo results in the induction of iT regs . Following immunization with ova in CFA, dLNs from WT OT-II mice contained 5.7% CD4 + Foxp3 + T cells while dLNs from C3ar1 −/− C5ar1 −/− OT-II mice contained 31% Foxp3 + CD4 + T cells (Fig. 5b) . Upon in vitro incubation for 24 h with ova and autologous splenic CD11c + DCs, C3ar1 −/− C5ar1 −/− OT-II T cells from the dLN produced more TGF-β1 and IL-10, but less IFN-γ than WT OT-II T cells in (Fig. 5c) . In a second experiment, we transferred WT Foxp3 − OT-II or C3ar1 −/− C5ar1 −/− Foxp3 − OT II cells to WT or C3ar1 −/− C5ar1 −/− recipients. Two days later, we immunized the mice with whole ovalbumin in IFA. Analyses of the dLNs five days later showed that 9.23 ± 1.34% (n=6) of the transferred cells were Foxp3 + when the donor and host were WT. In contrast, a higher percentage of Foxp3 + cells was seen when the recipient was C3ar1 −/− C5ar1 −/− and consequently devoid of C3a and C5a production (20.3±0.45%, n=6) or when the donor cells were derived from C3ar1 −/− C5ar1 −/− mice (27.4±2.2%, n=6). Notably, a much higher percentage (38.4±3.5%, n=6) of Foxp3 + cells was observed when both donor OT-II cells and the recipient mice were C3aR and C5aR deficient (Fig. 5d) .
We next compared the in vivo suppressive capacity of iT regs (all CD45.2 + Thy-1. (Fig. 5e ). Given the above findings that iT regs induced in the absence of C3aR and C5aR signals are stable in vivo whereas those induced with exogenous TGF-β1 are not, further studies are needed to determine whether the enhanced suppressor capacity of the latter groups was secondary to a true increase in suppressive function or secondary to enhanced stability in vivo. Nevertheless, the data show that C3ar1 −/− C5ar1 −/− iT regs suppress antigen specific T effector cells with high efficiency.
iT regs lacking C3aR and C5aR suppress autoimmune disease
We next evaluated the suppressive capacity of iT regs induced in the presence of C3aR and C5aR antagonists for the prevention and treatment of experimental autoimmune encephalomyelitis (EAE). We immunized Foxp3-GFP mice with MOG in CFA. When the clinical scores were > 2, we isolated CD4 + T cells from LNs and the spleen and purified Foxp3 − CD4 + T cells by cell sorting. We kept half of the Foxp3 -cells as a source of T effectors and stimulated the other half in the presence of C3aR-A plus C5aR-A to produce iT regs . We then transferred Foxp3 − T cells (4×10 6 ) alone or together with iT regs (1×10 6 ) into Rag2 −/− mice. While the Rag2 −/− recipients that received T effectors alone showed progressive weakness and weight loss, the recipients that also received C3aR-A + C5aR-A generated iT regs showed lesser disease with gradual improvement and recovery of their weights ( Fig. 6a and 6b) . At day 7 (Fig. 6c ) post adoptive transfer, Foxp3 + cells were detectable in LNs, spleens, and spinal cords from these mice, but not from mice that received the T effector population alone, indicating stability of Foxp3 expression on the transferred iT regs .
To evaluate whether iT regs generated ex vivo by C3aR + C5aR antagonism can modulate established EAE, we induced EAE in WT mice. We treated sick mice (scores >2) with Foxp3 + cells generated by stimulating naive CD4 + T cells from Foxp3-GFP mice in the presence of C3aR-A + C5aR-A. Following adoptive transfer of sorted Foxp3 + cells (1 × 10 6 ), clinical scores decreased and weights increased (Fig. 6d and 6e) . At days 7 and 14 ( Fig. 6f ) post adoptive transfer, Foxp3 + cells were detectable in LNs and spinal cords of the iT reg treated mice. Thus, the administration of a single dose iT regs induced ex vivo in the absence C3aR and C5aR signals can suppress ongoing EAE as well as prevent EAE induction.
C3aR and C5aR antagonism induces functional human iT regs
To date, it has been very difficult to generate functional human T regs in vitro by stimulating naive CD4 + T cells in the presence of TGF-β1 despite the fact that the cells express high levels of Foxp3 [33] [34] [35] [36] . To test whether C3aR + C5aR antagonism is effective in generating functional human iT regs , we incubated naive human CD45RA + CD25 − CD4 + T cells for 3 days with anti-CD3, IL-2, and DCs together with a) TGF-β1, b) C3aR-A + C5aR-A, or c) anti-C3a + anti-C5a mAbs. More than 95% of the cells generated in all three ways became Foxp3 + and were also CD25 + (Fig. 7a) . iT regs generated with C3aR-A plus C5aR-A or antiC3a plus C5a mAbs did not produce IL-2 in response to PMA plus ionomycin treatment, and did not proliferate when re-stimulated with anti-CD3 ( Supplementary Fig. 8a and 8b ). This contrasted with iT regs cells generated with TGF-β1 which, as reported by others 33 , produced IL-2, and proliferated upon re-stimulation. The CD25 + (Foxp3 + ) cells prepared by C3aR and C5aR antagonism either with the antagonists or mAbs exerted robust suppression (Fig. 7b) , whereas those prepared with TGF-β1 had little suppressive activity. Comparable results were obtained with iT regs generated from circulating CD45RA + CD25 − CD4 + T cells from 7 other individuals, three with asymptomatic multiple sclerosis (Fig. 7c) . Thus, in the absence of C3aR and C5aR signaling we were able to generate fully functional, bona-fide human iT regs .
DISCUSSION
The studies presented in this report highlight that complement, widely associated with innate immunity, plays an integral role in modulating T reg function/induction and dominant immunologic tolerance Previous studies 5 demonstrated that C3aR and C5aR signaling by cognate CD4 + T cells and DCs up-regulates costimulatory molecule expression on both partners, enhances survival of T effector cells 6, 7 , and increases T H 1 and T H 17 T effector function 5, 7 . Herein, we have examined in depth, the reverse situation. The major consequence of absent transmission C3aR and C5aR signals into CD4 + T cells resulting from absent C3a and C5a production of by antigen presenting cells is the induction of Foxp3 + iT regs without the addition TGF-β1. Thus, signaling in CD4 + T cells themselves via the C3aR and C5aR on the one hand potentiates immune responses, while the absence of this signaling diverts naive T cells to an iT reg response. The data support the concept that the differential regulation of C3a and C5a production and C3aR and C5aR signaling by TGF-β1 and IL-6 is a critical component of the induction of iT regs versus T H 17 effector cells 37 .
Collectively, these studies demonstrate that forward and backward feedback loops are involved in the induction of iT regs . First, the lack of C3aR and C5aR signaling in DCs results in enhanced TGF-β1 production by the DC and the consequent suppression of DC C3a and C5a production 5, 7 which deprives the responder T cells of their major source of C3a and C5a. The DC production of TGF-β1 prevents C3a and C5a production by the responder CD4 + T cells (or any other nearby cells) and evokes auto-inductive TGF-β1 signaling in the CD4 + T cell and its conversion to an iT reg . The iT reg produced TGF-β1 feeds back to induce auto-inductive TGF-β1 signaling in the DC and maintain the DC in an immature state. When C5aR signaling is disabled solely in the DC and the delivery of C3aR and C5aR signals into CD4 + T cells is not prevented, much lower percentages of Foxp3 + cells are induced (~5%) 8 . Thus, it is the dual absence of C3aR and C5aR signaling into the CD4 + T cells that is important, a concept that has not been previously explored.
Previous studies 5 showed that in addition to abolishing S 473 AKT phosphorylation, disrupting C3aR and C5aR signaling abolishes IL-2 and IFN-γ production. The analyses herein show that absent C3aR and C5aR signaling not only leads to disabled AKT phosphorylation, but also to disabled mTORC-1 dependent phosphorylation of rbS6 and disabled mTORC-2 (PDK2) dependent phosphorylation of the S 473 residue on AKT. We also demonstrate that absent C3aR and C5aR signaling in stimulated CD25 − CD4 + T cells is associated with STAT5 phosphorylation downstream of CD25 and not STAT3 phosphorylation as previously reported for tT regs 38 . A marked up-regulation of C5L2 was observed on iT regs generated with DCs devoid of C3a and C5a, while lower levels were seen on iT regs generated with exogenous TGF-β1. Although C5L2 was described more than 10 years ago 28, 39 , a physiological function has remained obscure. While C5L2 initially was hypothesized to function as a decoy receptor 29 , subsequent data concerning its specificity for C5a alone 40, 41 versus both C3a and C5a 42 , as well as its downstream signaling 26, 43, 44 have been conflicting. Recent studies 26 , however, have provided evidence that it scavenges C5a from C5aR by a β-arrestin dependent mechanism. Our studies demonstrate the capacity of C5L2 to scavenge C5a and thereby circumvent the transmission of C5aR signals. While others 8 concluded that there was no effect of C5L2 deficiency on T reg induction, they did not conduct their testing under conditions in which T regs were actually induced (i.e., in the presence of added TGF-β1). More in depth studies will be needed to determine the precise relationship between C5L2 expression and T reg suppressor function and stability.
We also compared TGF-β1 iT regs to C3aR and C5aR disabled iT regs in an in vivo assay 30 that measures iT reg stability. When antigen-specific iT regs prepared with TGF-β1 were transferred to a recipient challenged with their cognate antigen, they rapidly lost Foxp3 expression. In contrast, iT regs generated by C3aR and C5aR deficiency retained their Foxp3 expression. In addition, these iT regs were much more potent at inhibiting the expansion of co-transferred naive Foxp3 − T cells upon antigen challenge and could be used in a therapeutic mode to reverse the clinical course of established EAE. The molecular signals that underlie the enhanced stability of C3aR and C5aR disabled iT regs are not clear, as the TSDR region of the Foxp3 locus remained mostly methylated following induction in vitro.
We have not yet analyzed methylation of their TSDR following in vivo transfer, but the data argue that factors other than the methylation status of the TSDR may also regulate iT reg stability in vivo 31, 32 .
Our findings that human iT regs with robust suppressor function can be prepared from circulating human CD45RA + CD25 − CD4 + T cells by C3aR and C5aR antagonism could have value clinically in disorders in which suppression of T effector responses would be beneficial. Our previous studies of T effector responses 5, 7 showed that an advantage of this approach would be the concurrent suppression of T H 1 and T H 17 effector cell responses. Based on this study, a combination regimen incorporating an agent that blocks C3aR as well as C5aR signaling would constitute the optimal approach. It might also be of interest to incorporate these antagonists into regimens now used to expand human tT regs for cellular biotherapy where loss of Foxp3 expression remains a problem.
Many studies [45] [46] [47] [48] have implicated TLR signaling in DCs as triggering C3a and C5a production that would induce CD4 + T effector cell polarization. However, in the absence of external activation, there is no evidence that signaling through C3aR or C5aR at threshold levels needed for T effector responses occurs tonically in DCs or CD4 + T cells. Consequently, according to the linkage in this paper that absent C3aR and C5aR GPCR signaling leads to endogenous TGF-β1 production, the default state should be associated with TGF-β1 production and the induction of T regs . In principle, this pathway should be primarily operative during the generation of tolerogenic responses that naturally give rise to Foxp3 + iT regs to self-antigens or to iT regs to oral or airway antigens.
Taken together, the studies herein thus demonstrate a critical role for C3a and C5a in the differentiation of T regulatory cells as well as T effectors in vivo. Further studies using CD4 + T cell and DC specific C3 and C5 reporter mice guided by this work could enable detailed characterization of this important issue.
Materials and Methods

Reagents and antibodies
Murine C5a was from Cell Sciences. C3aR-A was purchased from Calbiochem (now EMD Biochemicals). C5aR-A synthetic peptide was kindly provided by John Lambris (Univ of Penn). Anti-mouse C3a (I87-1162) and C5a (I52-1486) mAbs were from BD Biosciences. Mouse IL-2, IL-10, IFN-γ, human IL-2, IL-10, IFN-γ and human TGF-β1 were from Prospec Bio. Anti-murine C5aR1 (20/70) was purchased from Abcam. Antibodies against mouse B7-1 (16-10A1), and B7-2 (GL1), were from BD Biosciences. Anti-CD40L mAb was from BioExpress. Anti-murine C3aR (sc-20138) was purchased from Santa Cruz Biotech. Anti-murine C5L2 (HP8015) was purchased from Hylcult Biotech. Anti-Human C3a (20C-CR6032RP) was purchased from Fitzgerald and anti-human C5a (AF2037) was purchased from R&D Systems. Mouse and Human anti-FoxP3 mAbs and T reg staining kits were purchased from eBiosciences. Anti-CD4 (RM-4-5, FITC), anti-Thy1.1 (HIS51, PE-Cy7), anti-Thy1.2 (53-2.1, APC), anti-CD45.1 (A20, PE), and anti-CD45.2 (104, APCeFluor 780) were purchased from eBiosciences. CFSE, CellTracker Red™, and CellTracker Violet™ were purchased from Invitrogen and used per the manufacturer's instructions. The TGF-βR1 inhibitor, anti-TGF-β1 mAb, and Smad3 inhibitor were kindly provided by John Letterio (CWRU).
Animals
Thy1.1, C57BL/6, OT-II, Rag2 −/− , C3 −/− , and C5 deficient mice were from Jackson labs. C3 −/− mice and C3ar1 −/− and C5ar1 −/− were gifts of Dr. Michael Carroll and Dr. Craig Gerard (Harvard). Foxp3-GFP Tg mice were a gift from Vijay Kuchroo (Harvard). C5 −/− C3 −/− mice were generated by crossing C5 deficient B10.D2 mice with C57BL/6 congenic C3 −/− mice. B6.SJL (CD45.1) and OT-II CD45.1 Rag −/− were obtained from Taconic Farms. All studies were approved by the Case Western Reserve University Institutional Animal Care and Use Center (IACUC).
RNA purification, cDNA synthesis, and qPCR mRNA expression was performed as previously described 5 .
Murine DCs and T cell isolations
CD11c + cells and CD4 + T cells were isolated from spleens and lymph nodes using the CD4 + negative selection cocktail or CD11c positive selection beads from Miltenyi per the manufacturer's instructions. Both were purified using the Automacs Pro. Foxp3 − and Foxp3 + CD4 + T cells were further purified via flow sorting gating on GFP + and GFP − populations.
T cell activation-1×10 6 CD62L hi CD25 − Foxp3 − CD4 + T cells were activated with anti-CD3 (3 μg/ml, or alternatively with anti-CD3+CD28 Dynabeads [Invitrogen] per the manufacturer's suggestion), 2.5×10 5 CD11c + DCs and rhIL-2 (5 ng/ml) with either rhTGF-β1 (5 ng/ml, Prospecbio), C3aR-A+C5aR-A (10 nM, Calbiochem and John Lambris as detailed above), or anti-C3a and anti-C5a mAbs (10 μg/ml, as detailed above).
Immunizations
Mice were immunized s.c. with OVA 323-339 or MOG 35-55 peptide as described 49 .
In vivo stability
T reg stability was measured as previously described 30 .
In vivo suppression 
Anti-CD3 and anti-CD28 stimulations
Cells were stimulated three different ways: 1) anti-CD3 (5 μg/ml) and/or anti-CD28 (BD Biosciences, San Diego, CA) in complete RPMI 1640 + 10% FBS; 2) anti-CD3 (5 μg/ml) and CD11c + DCs in complete RPMI 1640; or 3) with 1:1 ratio of T cell Dynabeads (Invitrogen) per the manufacturer's instructions.
FoxP3 + Staining Assays
For both Human and Murine T reg staining assays, the relevant FoxP3 + T regulatory staining kits (236A/E7 for Human and FJK-16s for mouse) were purchased from eBiosciences and used per the manufacturer's instructions. 
Murine T reg Suppression Assays
ELISAs
For C5a, C3a, IL-2, IL-10, and IL-6, capture and biotinylated detection Ab pairs were purchased from BD Biosciences. For TGF-β1, the human Ab pair (cross reacts with mouse) was purchased from eBiosciences. ELISAs were performed as previously described 5 .
Intracellular cAMP and Intracellular PKA Activity Assays
Intracellular cAMP levels were measured using cAMP-Glo Assay (Promega) and PepTag Assay (Promega) respectively.
Luminex Assay
Cells were restimulated with anti-CD3+anti-CD28 mAbs (5 μg/ml) and assayed for pAKT and tAKT using Millipore's Luminex assay according to the manufacturer's instructions.
Induction and Evaluation of EAE
EAE was induced and evaluated as previously described 7 .
Human T reg Isolation
The acquisition of blood products was approved according to the policies of the University Hospitals Cleveland Case Medical Center in accordance with the Declaration of Helsinki. Peripheral blood mononuclear cells (PBMCs) were obtained from 5 to 10 mL blood from healthy donors. 
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. (h) WT Foxp3 − CD4 + T cells were incubated for 3 days with WT DCs plus TGF-β1 (5 ng/ml) after which Foxp3 + and Foxp3 − cells were sorted. Foxp3 − CD4 + T cells or Foxp3 + CD4 + iT regs were incubated for 5 min with anti-CD3+CD28 beads + biotin-labeled C5a, the cells chilled to 4°C, and plasma membrane fractions were isolated by ultracentrifugation. Following C5aR and C5L2 IP, bound proteins were eluted with alkaline solution, and equal amounts of protein (determined by A 280 ) were loaded onto SDS PAGE gels. Following electrophoresis, gels were blotted for biotinylated-C5a by adding streptavidin-HRP followed by ECL reagent. 
